Advanced stage at diagnosis and aggressive histology dominate prostate cancer presentation in Kenya: a registry analysis
Résumé
Background Prostate cancer is the leading cause of cancer mortality among Kenyan men, with the majority diagnosed at advanced stages. This pattern likely reflects a combination of health system constraints, delayed diagnosis, and aggressive tumour biology. Prostate Specific Antigen (PSA) level, tumour stage, and WHO/ISUP grade groups are key clinical markers, yet their interrelationships and collective potential to inform risk stratified care remain poorly characterized in Kenyan populations. Methods We conducted a cross-sectional analysis of men with histologically confirmed prostate cancer enrolled in the International Registry for Men with Advanced Cancer (IRONMAN) and African Cancer Genomic Registry (ACGR) registries at two tertiary hospitals in Nairobi Kenyatta National Hospital (KNH) and MP Shah Hospital). Baseline PSA, tumour stage, and ISUP grade groups were abstracted from registry records. PSA values were available for 152 men, while ISUP grade groups for 168 and stage data were available for 170 men included in the stage-stratified analysis. Descriptive analyses and cross-tabulations were used to characterize the distribution and associations of these markers across localized vs. advanced disease. Results Of the 170 men included in the analysis, 26 (15.3%) presented with localized disease, while 144 (84.7%) had locally advanced or metastatic disease at diagnosis. PSA levels exhibited a strong gradient across tumour stages, with the likelihood of advanced disease increasing progressively with rising PSA categories. Men with PSA above 50 ng/mL predominantly presented with advanced-stage disease at 88%,. ISUP grade groups followed a parallel trend. The grades groups demonstrated a similar association with tumour stage, with lower-grade tumours more commonly observed among men with localized disease and higher-grade tumours predominating among advanced-stage cancers. The WHO/ISUP grade group 3 pattern was strongly associated with advanced disease at presentation. Collectively, these findings suggest that both late diagnosis and aggressive tumour biology contribute to the predominance of advanced-stage prostate cancer in this cohort. Conclusion PSA Categories demonstrated strong associations with tumour stage at diagnosis in Kenyan men with prostate cancer. Localized disease was uncommon, whereas advanced-stage presentation was frequently accompanied by markedly elevated PSA levels and high-grade histological features. These findings highlight the need for earlier diagnosis and improved access to timely diagnostic and referral pathways in Kenya.
Citer ce document
Exporter : BibTeX · RIS (Zotero, Mendeley, EndNote)
Accès au document
Texte intégral archivé sur SPHAERO, en accès ouvert : lisible gratuitement en ligne après connexion. Le document reste aussi disponible à sa source. Se connecter
Voir l'article sur le site de la revueLicence et provenance
Licence : CC BY
Notice moissonnée depuis OpenAlex le 19/10/2026. Le document reste hébergé par sa source.
Voir le document à la source →